Alys Pharmaceuticals Submits CTA for ALY-301 in Cold Urticaria
10 Jun 2025 //
PR NEWSWIRE
Alys Pharma Starts Phase IIa Trial of ALY-101 for Alopecia Areata
27 Mar 2025 //
PR NEWSWIRE
Alys Pharma Receives IND Clearance for Phase 2a Dermatology Trial
04 Feb 2025 //
PR NEWSWIRE